Publishing research using ab7837? Please let us know so that we can cite the reference in this datasheet.
ab7837 has been referenced in 3 publications.
McClean PL & Hölscher C Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.Neuropharmacology 76 Pt A:57-67 (2014).
Faivre E & Hölscher C D-Ala2GIP facilitated synaptic plasticity and reduces plaque load in aged wild type mice and in an Alzheimer's disease mouse model.J Alzheimers Dis 35:267-83 (2013).
McClean PL et al.The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease.J Neurosci 31:6587-94 (2011).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"